NCT07039760

Asciminib With or Without Sildenafil for Brain Tumors

RecruitingEARLY_PHASE1INTERVENTIONAL

Trial Details

Start: 2026-08-31Est. Completion: 2028-02-28

Enrollment target: 12 participants

Locations

Washington University School of Medicine/St. Louis Children's Hospital, St Louis, Missouri, United States

Contact

HER2-positive Breast Cancer

The purpose of this study is to assess the efficacy and safety of RO7771950 in combination with trastuzumab and capecita…

Clayton, AustraliaEst. completion May 1, 2029

Disease/Condition Name Cancer-related Cognitive DysfunctionChronic Lymphocytic Leukemia (CLL)Chronic Myeloid Leukemia, BCR-ABL1 Positive

This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for le…

Rochester, United StatesEst. completion Feb 28, 2029

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.